Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;196(5):e38-e40.
doi: 10.1111/bjh.17911. Epub 2021 Oct 20.

Interest of a third dose of BNT162b2 anti-SARS-CoV-2 messenger RNA vaccine after allotransplant

Amandine Le Bourgeois  1 , Marianne Coste-Burel  2 , Thierry Guillaume  3 , Pierre Peterlin  1 , Alice Garnier  1 , Berthe-Marie Imbert  2 , Thomas Drumel  2 , Beatrice Mahé  1 , Viviane Dubruille  1 , Nicolas Blin  1 , Anne Lok  1 , Cyrille Touzeau  1 , Thomas Gastinne  1 , Benoît Tessoulin  1 , Maxime Jullien  1 , Sophie Vantyghem  1 , Philippe Moreau  1 , Steven Le Gouill  1 , Marie C Béné  3   4 , Patrice Chevallier  1   3
Affiliations

Interest of a third dose of BNT162b2 anti-SARS-CoV-2 messenger RNA vaccine after allotransplant

Amandine Le Bourgeois et al. Br J Haematol. 2022 Mar.
No abstract available

Keywords: BNT162b2; allogeneic haematopoietic stem cell transplantation; coronavirus disease 2019 (COVID-19); severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) mRNA; third dose; vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest, except Dr Patrice Chevallier who received honoraria from Pfizer outside the submitted work.

References

    1. Walsh EE, Frenck RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. Safety and immunogenicity of two RNA‐Based Covid‐19 vaccine candidates. N Engl J Med. 2020;383:2439–50. - PMC - PubMed
    1. Ram R, Hagin D, Kikozashvilli N, Freund T, Amit O, Bar‐On Y, et al. Safety and immunogenicity of the BNT162b2 mRNA COVID‐19 vaccine in patients after allogeneic HCT or CD19‐based CART therapy‐A single‐center prospective cohort study. Transplant Cell Ther. 2021;27:788–94. - PMC - PubMed
    1. Redjoul R, Le Bouter A, Beckerich F, Fourati S, Maury S. Antibody response after second BNT162b2 dose in allogeneic HSCT recipients. Lancet. 2021;398:298–9. - PMC - PubMed
    1. Le Bourgeois A, Coste‐Burel M, Guillaume T, Peterlin P, Garnier A, Béné MC, et al. Safety and antibody response after 1 and 2 doses of BNT162b2 mRNA vaccine in recipients of allogeneic hematopoietic stem cell transplant. JAMA Netw Open. 2021;4:e2126344. - PMC - PubMed
    1. French Government. Precisions sur la vaccination COVID‐19: modalités d'administration des rappels et vaccination des personnes immunodeprimées et de leurs proches. May 6, 2021. Available at: https://solidaritessante.gouv.fr/IMG/pdf/dgs_urgent_52_precisions_sur_la.... Accessed October 2021.